Jump to content

WIN 54,461

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:03, 21 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

WIN 54,461
Identifiers
  • [6-bromo-2-methyl-1-(2-morpholin-4-ylethyl)-1H-indol-3-yl](4-methoxyphenyl)methanone
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H25BrN2O3
Molar mass457.368 g·mol−1
3D model (JSmol)
  • Brc4ccc2c(n(c(c2C(=O)c1ccc(OC)cc1)C)CCN3CCOCC3)c4

WIN 54,461 (6-Bromopravadoline) is a drug that acts as a potent and selective inverse agonist for the cannabinoid receptor CB2.[1]

See also

References

  1. ^ Howlett AC, Berglund B, Melvin LS (October 1995). "Cannabinoid Receptor Agonists and Antagonists". Current Pharmaceutical Design. 1 (3): 343–352.


Stub icon

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=WIN_54,461&oldid=963674251"